• Mashup Score: 51
    | AHA/ASA Journals - 5 day(s) ago

    Circulati on: Heart Failure is proud to launch a new and exclusive educational series tailored for current advanced heart failure fellows and early-career attendings (within two years of fellowship completion). This year-long course is designed to: – Expand your clinical knowledge – Facilitate meaningful peer and mentor connections – Provide direct exposure to the editorial and research environment of Circulation: Heart Failure The program includes: – Eight 60-90 minute live, virtual sessions led by

    Tweet Tweets with this article
    • 📣Calling all #AHFTC Fellows! @CircHF is proud to launch a free educational webinar series for current or past AHFTC fellows. 📍8 live virtual sessions, 1 in-person event 📍New topic each session đź“…Start Date: August 13, 2025 đź”—Learn More: https://t.co/sPBjhJimND https://t.co/Pd5pwJrCbJ

  • Mashup Score: 19

    Circulation: Heart Failure welcomes authors whose presentations have been accepted at the upcoming 2025 European Society of Cardiology (ESC) Congress to submit their manuscripts for consideration for expedited review and potential simultaneous publication. To be considered, authors must submit their manuscripts through the Journal’s submission site by June 23. Authors should indicate in their cover letter, as well as in the “Meeting Presentation” section of the submission form, that they are seeking

    Tweet Tweets with this article
    • 📢Expedited Review for #ESCCongress 2025! @CircHF invites authors with accepted ESC presentations to submit manuscripts for rapid review. 📍Initial decisions within 10 days! 📝Submit by June 23 đź”—Learn More: https://t.co/KHnShz5Jv2 #AHAJournals @DrNancySweitzer @JamesCFangMD https://t.co/GHagqMLz3I

  • Mashup Score: 30

    BACKGROUND: Despite randomized data for survival benefit (with class 1 recommendations) for treating heart failure (HF) with reduced ejection fraction using quadruple medical therapy (QMT)—defined as evidence-based β-blockers, sodium-glucose cotransporter 2 inhibitor, preferably angiotensin receptor/neprilysin inhibitor, and mineralocorticoid receptor antagonist—it is underutilized. IMPLEMENT-HF is a multiregional HF quality improvement initiative to improve care and outcomes for patients with HF by enhancing the use of QMT in routine practice. METHODS: This analysis of HF with reduced ejection fraction treatment in patients from hospitals participating in the American Heart Association’s Get With The Guidelines–HF who volunteered to participate in IMPLEMENT-HF in 7 US regions. IMPLEMENT-HF included multidisciplinary learning to share strategies for formulary changes, electronic health record tools, and patient resources with site-level feedback reports. Participants gathered QMT data

    Tweet Tweets with this article
    • IMPLEMENT-HF: defect-free GDMT therapy use in HFrEF: from 4.7% to 44.6% at discharge—improving care across 7 U.S. regions @GCFMD @kofi_larry @NMHHeartdoc @MKittlesonMD @DrNancySweitzer @JavedButler1 @cdbeon @AndrewJSauer @MidAmericaHeart @saintlukeskc https://t.co/SHi1VIfKpK https://t.co/vDxbfjutXL

  • Mashup Score: 50
    | AHA/ASA Journals - 9 day(s) ago

    Circulati on: Heart Failure is proud to launch a new and exclusive educational series tailored for current advanced heart failure fellows and early-career attendings (within two years of fellowship completion). This year-long course is designed to: – Expand your clinical knowledge – Facilitate meaningful peer and mentor connections – Provide direct exposure to the editorial and research environment of Circulation: Heart Failure The program includes: – Eight 60-90 minute live, virtual sessions led by

    Tweet Tweets with this article
    • 📣Calling all #AHFTC Fellows! @CircHF is proud to launch a free educational webinar series for current or past AHFTC fellows. 📍8 live virtual sessions, 1 in-person event 📍New topic each session đź“…Start Date: August 13, 2025 đź”—Learn More: https://t.co/sPBjhJimND https://t.co/Pd5pwJrCbJ

  • Mashup Score: 53

    The pulsatile nature of blood flow and the hydrostatic effect of pulmonary capillary wedge pressure are 2 fundamental, yet often overlooked features of right ventricular-pulmonary arterial interactions in advanced heart failure and cardiogenic shock. These 2 features (above all others) define both the mechanical forces experienced by the pulmonary arteries, and in turn, the vascular afterload imposed by the pulmonary circulation on the right ventricular. For over half a century, it has been assumed that the pulsatile components of the pulmonary circulation exist in predictable and constant proportion to resistive afterload. In other words, that the vascular afterload can be estimated from mean pulmonary arterial pressure and pulmonary vascular resistance alone. While this tenet holds true for most forms of pulmonary hypertension, pulmonary hypertension resulting from the passive transmission of elevated left atrial pressure is a notable exception. In these cases, arterial compliance de

    Tweet Tweets with this article
    • Reframing pulmonary vascular afterload in HF and CS: PCWP and pulsatility are key to RV-PA interactions @navinkapur4 @KayEverettMDPhD @Sydney_Uni @heartfoundation #AHAJournals https://t.co/WdiJXgPGlB https://t.co/a8KecOCBsJ

  • Mashup Score: 31

    BACKGROUND: Patients with lung disease, sleep apnea, and chronic thromboemboli can develop pulmonary hypertension, currently classified as group 3 or 4. Many of these patients also have risk factors for heart failure with preserved ejection fraction (HFpEF), but the optimal approach to identify the disease overlap remains unclear. METHODS: Pretest probability for HFpEF was determined using the HFpEF-ABA algorithm among adjudicated group 3 or 4 patients at risk for pulmonary hypertension in the PVDOMICS study (Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics). Patients were stratified by current resting right heart catheterization criteria, and in a separate analysis, stratified only by HFpEF-ABA probability into low (<25%), intermediate, and high (≥75%) HFpEF probability groups. RESULTS: Among 598 patients with group 3 disease, 27% (n=161) had elevated pulmonary capillary wedge pressure (PCWP) with postcapillary pulmonary hypertension even at rest, which w

    Tweet Tweets with this article
    • Higher HFpEF probability in group 3/4 PH is associated with dynamic PCWP abnormalities, worse functional status and quality of life. @yreddyhf @mayoclinicCV @JaneALeopold @FrantzDrBob @WilsonTangMD @bborlaugmd @ebrosenzweig @SteveMathaiMD @ChrisJellisMD https://t.co/B4IdpK0e1K https://t.co/aUDFTRCv93

  • Mashup Score: 82

    Recent findings emphasize the potential role of invasive hemodynamic assessment in guiding transcatheter mitral and tricuspid valve percutaneous interventions. Right heart catheterization-derived parameters offer insights into hemodynamic changes associated with valvular heart diseases, pulmonary hypertension phenotyping, and right ventricular to pulmonary artery coupling. This might improve prognostic stratification for candidates to transcatheter therapies. This review provides a clinical overview of available data regarding the utility of preoperative right heart catheterization-derived parameters in patients undergoing mitral and tricuspid percutaneous repair or replacement.

    Tweet Tweets with this article
    • Hemodynamic Right Heart Catheterization Before Transcatheter Mitral and Tricuspid Therapies @Dr.LucaTesta @saia_francesco @azeemlatib @RyanTedfordMD @RodrigoEstvez1 @CaravitaSergio @andrea_muna @antosis_93 @coppifrancesca @lucaraone @SparasciF @GodinoCosmo https://t.co/jUJHx6CBei https://t.co/LgaPYTXOLB

  • Mashup Score: 13

    View all available purchase options and get full access to this article. Rossong H, Debreuil S, Yan W, Hiebert BM, Singal RK, Arora RC, Yamashita MH. Long-term survival and quality of life after extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2023;166:555–566.e2. doi: 10.1016/j.jtcvs.2021.10.077 Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet J-L, Léger P, Pavie A, Chastre J. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory

    Tweet Tweets with this article
    • Forgotten After Discharge? ECMO Patients Deserve Better @RealShanModi #AHAJournals https://t.co/GT6GfGhBZi